Understanding HER2 Low Breast Cancer

Topics Covered

• Overview of HER2 Low Breast Cancer
• What is the HER2 Status of My Cancer? What does this Mean?
• Diagnostic Testing: What is an Immunohistochemistry (IHC) Test or Fluorescence In Situ Hybridization (FISH) Test
• The Role of the Pathologist
• The Role of the Genetic Counselor
• Standard Treatment Options, Including Targeted Therapy
• How Biomarker Testing Informs Treatment Decisions
• New Targeted Treatments
• Updates on Investigational New Drugs in Clinical Trials
• How Research Contributes to Treatment Options
• What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort & Pain
• The Role of the Dietitian
• Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns for HER2 Low Breast Cancer
• Questions for Our Panel of Experts

Our Panel of Experts

Paolo Tarantino, MD, PhD

Breast Medical Oncologist, Clinical Researcher, Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School

Kamel Abou Hussein, MD

Assistant Professor of Medicine, Cooper Medical School of Rowan University, Adjunct Assistant Professor, Department of Breast Medical Oncology, MD Anderson Cancer Center, Co-Director of the Janet Knowles Breast Cancer Program, Director of Breast Cancer Clinical Trials, MD Anderson Cancer Center at Cooper

Mara H. Rendi, MD, PhD

Pathologist specializing in Breast Cancer, Abbott Northwestern Hospital, Hospital Pathology Associates and Allina Health, Minneapolis, Minnesota

Kara R. (Schoeffel) Rogen, MS, CGC

Licensed Certified Genetic Counselor, Department of Clinical Genomics, Mayo Clinic

Diana L. Bearden, MS, RD, CSO, LD, CNSC

Oncology Dietitian, Michael E. DeBakey VA Medical Center

Cassie Spector, MSW, OSW-C

Breast and Gynecological Cancers Program Coordinator, CancerCare

Continuing Education Credits

(Live Only)

Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.

Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.

Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).

To request continuing education paperwork, please email your name, profession and address to connect@cancercare.org after the program. All paperwork for continuing education credit must be requested, completed and submitted within two weeks of the live program.

Brochure

You can download the brochure for this workshop